Madhurima Anne, MD, discusses the practice-changing data of the phase 3 DESTINY-Breast04 trial in patients with HER2-low breast cancer.
Madhurima Anne, MD
Advertisement
Articles by Madhurima Anne, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Data Refine the Role of Immunotherapy Across Early-Stage NSCLC Settings
2
Dr Tarantino on the Evolution of TROP2-Directed ADCs in First-Line TNBC
3
Docetaxel Remains Unbeaten in Immunotherapy-Refractory NSCLC
4
Dr Hurvitz on Updated PFS Data From the SERENA-6 Trial in Breast Cancer
5